0001209191-21-043532.txt : 20210628
0001209191-21-043532.hdr.sgml : 20210628
20210628182114
ACCESSION NUMBER: 0001209191-21-043532
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210624
FILED AS OF DATE: 20210628
DATE AS OF CHANGE: 20210628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Walsh Colin
CENTRAL INDEX KEY: 0001866174
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40523
FILM NUMBER: 211054990
MAIL ADDRESS:
STREET 1: C/O ELEVATION ONCOLOGY, INC.
STREET 2: 888 SEVENTH AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elevation Oncology, Inc.
CENTRAL INDEX KEY: 0001783032
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 841771427
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 888 SEVENTH AVE
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
BUSINESS PHONE: 212-651-6380
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVE
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
FORMER COMPANY:
FORMER CONFORMED NAME: 14ner Oncology, Inc.
DATE OF NAME CHANGE: 20190719
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-24
0
0001783032
Elevation Oncology, Inc.
ELEV
0001866174
Walsh Colin
C/O ELEVATION ONCOLOGY, INC.
888 SEVENTH AVENUE, 12TH FLOOR
NEW YORK
NY
10106
1
0
0
0
Director Stock Option (Right to Buy)
16.00
2021-06-24
4
A
0
31238
0.00
A
2031-06-23
Common Stock
31238
31238
D
The stock option vests as of 1/36 of the total shares monthly beginning on July 24, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Shawn Leland, Attorney-in-Fact
2021-06-28